Tinea capitis caused by Microsporum praecox in a patient with sickle cell anaemia

REFERENCES

• Aertgeerts P., De Vroey C. Isolements de Microsporum praecox Rivalier, en Belgique. Bulletin de la Société Française de Mycologie Médicale 1981; 10: 17–20
   Google Scholar
• Ajello L., Georg L.K. In vitro hair cultures for distinguishing between atypical isolates of Trichophyton mentagrophytes and Trichophyton rubrum. Mycopathologia 1957; 8: 3–17
   Google Scholar
• Allen D.E., Snyderman R., Meadows L., Pinnell S.R. Generalized Microsporum audouinii infection and depressed cellular immunity associated with a missing plasma factor required for lymphocyte blastogenesis. American Journal of Medicine 1977; 63: 991–1000
   PubMed Web of Science ®Google Scholar
• Avram A., Gauchy O., Blanchart P., Buot G. Trois cas de dermatophyte à Microsporum praecox. Bulletin de la Société Française de Mycologie Médicale 1988; 17: 329–334
   Google Scholar
• Badillet G., Castillo S., Ghoti C. Isolement à Paris de Microsporum praecox. Bulletin de la Société Française de Mycologie Médicale 1978; 7: 299–304
   Google Scholar
• De Vroey C., Song M., Wiame L., Achten G. Infections cutanées par Microsporum praecox. Bulletin de la Société Française de Mycologie Médicale 1983; 12: 71–73
   Google Scholar
• De Vroey C., Wuytack-Raes C., Fossoul F. Isolation of saprophytic Microsporum praecox Rivalier from sites associated with horses. Sabouraudia 1983; 21: 255–257
   PubMedGoogle Scholar
• Gavrilis P., Rothenberg S.P., Guy R. Correlation of low-serum IgM levels with absence of functional splenic tissue in sickle cell disease syndromes. American Journal of Medicine 1974; 57: 542–545
   PubMed Web of Science ®Google Scholar
• Glassman A.B., Deas D.V., Berlinsky F.S., Bennett C.E. Lymphocyte blast transformation and peripheral lymphocyte percentages in patients with sickle cell disease. Annales of Clinical Laboratory Science 1980; 10: 9–12
   PubMed Web of Science ®Google Scholar
• Johnston R.B., Jr., Newman L.S., Struth A.G. An abnormality of the alternative pathway of complement activation in sickle cell disease. New England Journal of Medicine 1973; 288: 803–808
   PubMed Web of Science ®Google Scholar
• Koethe S.M., Casper J.T., Rondeu G.E. Alternative complement pathway activity in sera from patients with sickle cell disease. Clinical Experimental Immunology 1976; 23: 56–60
   PubMed Web of Science ®Google Scholar
• Pearson H.A., Spencer R.P., Cornelius E.A. Functional asplenia in sickle cell anemia. American Journal of Medicine 1969; 281: 923–926
   Google Scholar
• Phelippot R., Feuilhade De Chauvin M., Michel Y., Pietrini P., Teillac D., Boniatsi L., Badillet G. Microsporum praecox: à propos de quatre observations. Journées Dermatologiques de Paris 1988; 115: 1154–1156
   Google Scholar
• Rivalier E. Description de Sabouraudites praecox nova species suivie de remarques sur les genre Sabouraudites. Annales de l'Institut Pasteur 1954; 86: 276–284
   PubMedGoogle Scholar
• Rivalier E. Microsporum praecox. Bulletin de la Société Française de Mycologie Médicale 1978; 7: 297–297
   Google Scholar
• Voss E.G., Burdent H.M., Chaloner W.G., Demoulin V., Hiepko P., McNeil J., Meikil R.D., Nicholson D.H., Rollins R.C., Silva P.C., Greuter W. (1983) International Code of Botanical Nomenclature adopted by the 13th International Botanical Congress, Sydney, August, 1981. Bohn. Scheltema & Holkema, UtrechtNetherlands
   Google Scholar
• Weitzman I., McMillen S. Isolation in the United States of a culture resembling M. praecox. Mycopathologia 1980; 70: 181–186
   PubMed Web of Science ®Google Scholar
• Weitzman I., Silva-Hutner M. Non-keratinous agar media as substrates for the ascigerous state in certain members of the Gymnoascaceae pathogenic for man and animals. Sabouraudia 1967; 5: 335–340
   PubMedGoogle Scholar
• Winkelstein J.A., Drachman R.H. Deficiency of pneumococcal serum opsonizing activity in sickle cell disease. New England Journal of Medicine 1968; 279: 459–466
   PubMed Web of Science ®Google Scholar